Cheri Deal , Ph.D. , M.D.
    Cheri Deal
    Research Axis
    Fetomaternal and Neonatal Pathologies Axis
    Research Theme
    Mechanisms for congenital anomalies
    CHUSJ - Centre de Recherche

    514 345-4735

    514 345-4988

    Career Summary

    Dr. Deal obtained her PhD (Experimental Medicine), funded by the Medical Research Council of Canada (CIHR), at McGill University, followed by her MD degree at the University of Montreal. She is Canadian and American board certified in Pediatrics (CHU Sainte-Justine/Montreal Children's Hospital) and in Pediatric Endocrinology. She obtained a Medical Research Council Scholarship to pursue a research fellowship in the laboratory of Dr. Ron Rosenfeld at Stanford University in Pediatric Endocrinology from 1989-1991. Dr. Deal has been on staff with the Endocrine Service at CHU Sainte-Justine since 1992, and is tenured Full Professor with the Department of Pediatrics at the University of Montreal as well as an Associate Member of the Faculty of Medicine (Division of Experimental Medicine) of McGill University. Her administrative experience includes the position of past President of the Canadian Pediatric Endocrinology Group (1999-2001), President of the Canadian Society of Endocrinology and Metabolism (2009 – 2011) as well as a member and secretary of the Board of Directors of the Fonds de la recherche en santé du Québec (FRSQ)(1999- 2006). She has served as site leader for the Canadian Institutes of Health Research (C.I.H.R.) Canadian Clinical Scientist Training Program in Pediatrics, and is currently Program Director for Pediatric Endocrinology and Metabolism at the University of Montreal.

    Her major research interest is in the contribution of the growth hormone-insulin-like growth factor (GH-IGF) axis to the regulation of human growth. One of her laboratory focuses has been the genetic and epigenetic regulation of IGF2. She received support from the Canadian Breast Cancer Research Initiative to study the role of IGF2 and its receptor in breast cancer. Her secondary field of focus concerns the regulation of various other members of the GH-IGF axis in post-natal life, their role in carcinogenesis, within the context of pre-pubertal obesity, and as a target for clinical intervention in children with Turner Syndrome. Dr. Deal has a strong commitment to patient-driven research, and has helped to elucidate the molecular defects associated with a wide range of rare pediatric endocrine disorders including Type 1 polyglandular autoimmune syndrome (APECED) and congenital hypopituitarism and , as well as participated in clinical studies aimed at ameliorating outcomes in a variety of pediatric endocrine diseases such as congential hypothyroidism, precocious puberty, Prader-Willi syndrome and Turner syndrome. She has over 100 publications.

    Awards and Distinctions

    • Lawson Wilkins Pediatric Endocrine Society Clinical Scholar Award, 1994
    • FRSQ Research Scholarships, 1996, 2001 and 2004

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931


© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security


Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine